DISABLED ENTREPRENEUR – DISABILITY UK
Disability UK Online Health Journal – All In One Business In A Box – Forum – Business Directory – Useful Resources – Health – Human Rights – Politics
DISABLED ENTREPRENEUR – DISABILITY UK
Disability UK Online Health Journal – All In One Business In A Box – Forum – Business Directory – Useful Resources – Health – Human Rights – Politics
Browsing Category
Multiple sclerosis research has produced an intriguing new development following the publication of a study involving an experimental medicine called kamuvudine-9, also known as K-9. Researchers have reported that K-9 was able not only to prevent further neurological deterioration in a laboratory model of multiple sclerosis but also to reverse existing paralysis and vision loss in mice.
Professor Tal Dvir and Tel Aviv University are developing personalised stem-cell spinal cord implants that restored walking in paralysed animals, with the first potential human treatment being prepared for 2027.
Every new discovery in genetics brings scientists one step closer to understanding complex conditions and improving the lives of those affected. Learn how MIRAGE syndrome was discovered in 2016 through genetic sequencing and why this rare SAMD9-related disorder is one of the rarest medical conditions in the world.
Learn about Oral-Facial-Digital Syndrome Type 2 (OFD2), a rare genetic condition that affects facial, oral, and digital development. Understand the symptoms, impact, and how to support individuals living with OFD2.
Disclaimer: This article is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment. Always seek advice from qualified healthcare professionals regarding …
In a historic medical breakthrough, a three-year-old child has become the youngest patient ever to receive a revolutionary form of gene therapy, offering hope to families affected by rare and life-threatening genetic conditions. The pioneering treatment, administered at a leading children’s hospital in the UK, has shown early signs of success and could change the trajectory of treatment for similar disorders worldwide.